Table 2.
Underlying liver diseases (n = 144 patients)
| HCV liver cirrhoses overall | 54 (37.5%) |
|---|---|
| HCV liver cirrhoses + HCC | 20 (13.9%) |
| HBV liver cirrhoses overall | 16 (11.1%) |
| HBV liver cirrhoses +HCC | 7 (4.9%) |
| HCC overall | 41 (28.5) |
| Alcoholic liver cirrhosis overall | 24 (16.7%) |
| Alcoholic liver cirrhosis + HCC | 1 (0.7%) |
| Alcoholic liver cirrhosis + HBV | 1 (0.7%) |
| Acute liver failure | 12 (8.3%) |
| PSC | 5 (3.5%) |
| PBC | 4 (2.8%) |
| Morbus Wilson | 4 (2.8%) |
| Cryptogenic liver cirrhosis | 2 (1.4%) |
| Amyloidosis | 3 (2.1%) |
| Budd chiari syndrome | 2 (1.4%) |
| Alpha-1-antitrypsin deficiency | 1 (0.7%) |
| AIH liver cirrhosis | 1 (0.7%) |
| Polycyclic liver disease | 1 (0.7%) |
| Hyperoxalurie | 1 (0.7%) |
| Vanishing bile duct syndrome | 1 (0.7%) |
| M. Osler | 1 (0.7%) |
AIH, autoimmune hepatitis; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis.